0001062993-23-011845.txt : 20230519 0001062993-23-011845.hdr.sgml : 20230519 20230519165643 ACCESSION NUMBER: 0001062993-23-011845 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230517 FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ashton William CENTRAL INDEX KEY: 0001474553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 23941188 MAIL ADDRESS: STREET 1: C/O HARRISON CONSULTING GROUP STREET 2: PO BOX 283 CITY: NEWTOWN SQUARE STATE: PA ZIP: 19073 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Societal CDMO, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 E. UWCHLAN AVE, SUITE 112 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 770-534-8239 MAIL ADDRESS: STREET 1: 1 E. UWCHLAN AVE, SUITE 112 CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: Recro Pharma, Inc. DATE OF NAME CHANGE: 20131010 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0407 4 2023-05-17 0001588972 Societal CDMO, Inc. SCTL 0001474553 Ashton William C/O SOCIETAL CDMO, INC. 1 E UWCHLAN AVE, SUITE 112 EXTON PA 19341 1 0 0 0 0 Common Stock 2023-05-17 4 A 0 73620 A 241400 D Stock Option (right to buy) 0.74 2023-05-17 4 A 0 27229 0 A 2033-05-17 Common Stock 27229 27229 D These restricted stock units will vest in full on May 17, 2024, subject to continued service with the Company. Restricted stock units convert into common stock on a one-for-one basis. The stock option will vest in full on May 17, 2024, subject to continued service with the Company. /s/ Ryan D. Lake, Attorney-in-Fact 2023-05-19